Lori Berk
Impact in
-
- PI3K/AKT/mTOR signaling in cancer
- Epigenetics and DNA Methylation
- DNA Repair Mechanisms
- Genetics top 10%
- Genetics and Neurodevelopmental Disorders
- Genomic variations and chromosomal abnormalities
- Chronic Lymphocytic Leukemia Research
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 6
- Viral Infectious Diseases and Gene Expression in Insects 2
- RNA Interference and Gene Delivery 2
- Genetics 7
- Genetics and Neurodevelopmental Disorders 3
- Virus-based gene therapy research 3
- Genomic variations and chromosomal abnormalities 2
- Co-authors
- Victor M. Rivera (16 shared papers)Tim Clackson (9 shared papers)Kay Huebner (3 shared papers)Teresa Druck (3 shared papers)Frank G. Haluska (5 shared papers)John W. Loewy (3 shared papers)Koshi Mimori (2 shared papers)Hansjüerg Alder (2 shared papers)
- Journals
- Cold Spring Harbor Protocols (3 papers)Blood (2 papers)Proceedings of the National Academy of Sciences (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Lori Berk
20 papers receiving 799 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 502
- Genetics 195
- Genetics 65
- Oncology 163
- Pulmonary and Respiratory Medicine 183
Countries citing papers authored by Lori Berk
This map shows the geographic impact of Lori Berk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Berk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Berk more than expected).
Fields of papers citing papers by Lori Berk
This network shows the impact of papers produced by Lori Berk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Berk. The network helps show where Lori Berk may publish in the future.
Co-authors
The 25 scholars most cited alongside Lori Berk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 204 | |
| 2 | 1999 | 106 | |
| 3 | 2011 | 89 | |
| 4 | 2009 | 76 | |
| 5 | 2001 | 60 | |
| 6 | 2009 | 50 | |
| 7 | 2010 | 38 | |
| 8 | 2012 | 33 | |
| 9 | FHITness and cancer. | 1998 | 30 |
| 10 | 2009 | 28 | |
| 11 | 2005 | 24 | |
| 12 | 2011 | 17 | |
| 13 | 2012 | 15 | |
| 14 | 2012 | 15 | |
| 15 | 2005 | 15 | |
| 16 | 2008 | 7 | |
| 17 | 2012 | 6 | |
| 18 | 2012 | 5 | |
| 19 | 2004 | 3 | |
| 20 | 2004 | 1 |
About Lori Berk
Lori Berk is a scholar working on Molecular Biology, Genetics, Hematology, Oncology and Surgery, having authored 20 papers that have together received 822 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), Genetics and Neurodevelopmental Disorders (3 papers), Virus-based gene therapy research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Multiple Myeloma Research and Treatments (2 papers), RNA Interference and Gene Delivery (2 papers) and Genomic variations and chromosomal abnormalities (2 papers). The work is most often cited by research in Molecular Biology (502 citations), Genetics (195 citations), Genetics (65 citations), Oncology (163 citations) and Pulmonary and Respiratory Medicine (183 citations). Lori Berk has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Victor M. Rivera, Tim Clackson, Kay Huebner, Teresa Druck, Frank G. Haluska, John W. Loewy, Koshi Mimori, Hansjüerg Alder, Carlo M. Croce and Monica Mita. Their work appears in journals such as Cold Spring Harbor Protocols, Blood, Proceedings of the National Academy of Sciences, Cancer Chemotherapy and Pharmacology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.